Compare OMDA & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMDA | LMRI |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | 946 | N/A |
| Industry | Medical/Nursing Services | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2025 | 2025 |
| Metric | OMDA | LMRI |
|---|---|---|
| Price | $18.86 | $11.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $28.42 | $17.67 |
| AVG Volume (30 Days) | ★ 1.0M | 300.2K |
| Earning Date | 11-05-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.27 | N/A |
| EPS | 0.04 | ★ 0.05 |
| Revenue | ★ $260,210,000.00 | N/A |
| Revenue This Year | $30.17 | $4.26 |
| Revenue Next Year | $20.40 | $5.41 |
| P/E Ratio | $474.75 | ★ $218.40 |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $10.28 | $6.45 |
| 52 Week High | $26.92 | $19.45 |
| Indicator | OMDA | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 63.54 |
| Support Level | $18.74 | $11.10 |
| Resistance Level | $21.76 | $11.57 |
| Average True Range (ATR) | 1.07 | 0.44 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 30.97 | 98.19 |
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.